These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2904397)

  • 1. [Cardioprotection through ACE inhibition. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 26 May 1988, Kyoto, Japan].
    Fortschr Med Suppl; 1988; 51():1-17. PubMed ID: 2904397
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive strategy using angiotensin converting inhibitors. Official satellite symposium to the 12th scientific meeting of the International Society of Hypertension. Kyoto, Japan, May 27, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S1-80. PubMed ID: 2474094
    [No Abstract]   [Full Text] [Related]  

  • 3. Peripheral haemodynamics and angiotensin converting enzyme inhibition. Satellite symposium of the twelfth scientific meeting of the International Society of Hypertension. 21 May 1988, Kyoto, Japan.
    J Hypertens Suppl; 1988 Dec; 6(3):S1-85. PubMed ID: 3225685
    [No Abstract]   [Full Text] [Related]  

  • 4. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 5. ACE inhibitors and the kidney. Proceedings of a satellite symposium held in conjunction with the International Society of Hypertension. Kyoto, Japan, May 21, 1988.
    Nephron; 1990; 55 Suppl 1():1-98. PubMed ID: 2345588
    [No Abstract]   [Full Text] [Related]  

  • 6. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
    Greminger P; Vetter W
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACE inhibition in tissues. Decisive for prognosis?].
    MMW Fortschr Med; 2002 Mar; 144(11):60. PubMed ID: 12066521
    [No Abstract]   [Full Text] [Related]  

  • 8. The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.
    Liao Y; Husain A
    Can J Cardiol; 1995 Aug; 11 Suppl F():13F-19F. PubMed ID: 7664213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?
    Pellizzer AM; Krum H
    Aust Fam Physician; 1996 Jul; 25(7):1067-9, 1072-3, 1076-7. PubMed ID: 8768273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ACE inhibitor therapy in treating cardiovascular disease.
    Flint L
    Nurs Times; 2004 Mar 23-29; 100(12):34-7. PubMed ID: 15067910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors: present and future. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 28 May 1988, Osaka, Japan.
    J Hypertens Suppl; 1989 Apr; 7(2):S1-87. PubMed ID: 2666606
    [No Abstract]   [Full Text] [Related]  

  • 13. Current indications for ACE inhibitors and HOPE for the future.
    Burch S; Ou N
    Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE-inhibition: state of the art. Symposium held during the Xth Congress of the European Society of Cardiology. Vienna, August 31, 1988. Proceedings.
    Cardiology; 1989; 76 Suppl 2():1-68. PubMed ID: 2766310
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. New aspects of renin research. Kyoto, Japan, May 27, 1988. Proceedings.
    Clin Exp Hypertens A; 1988; 10(6):1127-327. PubMed ID: 3066522
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE; Julius S
    Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of angiotensin-converting enzyme, kinins and nitric oxide in circulation and the beneficial effects of ACE inhibitors in cardiovascular diseases.
    Magen E; Viskoper RJ
    Isr Med Assoc J; 2000 Dec; 2(12):929-34. PubMed ID: 11344778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha1-blockers with additional antihypertensive mechanisms. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 28 May 1988, Kyoto, Japan.
    J Hypertens Suppl; 1988 Dec; 6(2):S1-73. PubMed ID: 2906694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.